Cargando…

Novel resistance mechanism of HIV-1 To peptide fusion inhibitors

Detalles Bibliográficos
Autores principales:	Gupta, Nidhi, Vassell, Russell, Wang, Wei, He, Yong, Weiss, Carol D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1717000/ http://dx.doi.org/10.1186/1742-4690-3-S1-S86

Ejemplares similares

Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics
por: De Feo, Christopher J, et al.
Publicado: (2014)

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

Potent suppression of HIV viral replication by a novel inhibitor of Tat
por: Mousseau, Guillaume, et al.
Publicado: (2012)

The changing face of HIV resistance; HIV drug resistance north and south — what's next?
por: Schapiro, J
Publicado: (2010)

An unprecedented and simple gp120 switch mechanism enables HIV-1 to overcome multiple entry inhibitors and tropism limitations
por: Platt, Emily, et al.
Publicado: (2006)

Mutational analysis of HIV-1 gp41 mediated apoptosis and its correlation with fusion/hemifusion
por: Garg, Himanshu, et al.
Publicado: (2006)

Optimization and antiviral analysis of peptide ligands for the HIV-1 packaging signal PSI
por: Dietz, Julia, et al.
Publicado: (2006)

Influence of Duffy antigen receptor for chemokines on HIV infection
por: Weiss, Robin
Publicado: (2013)

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)
por: Eron, J, et al.
Publicado: (2010)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

A novel physiological significance of natriuretic peptides in cancer metastasis
por: Kangawa, Kenji, et al.
Publicado: (2013)

Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor
por: Allaway, Graham P
Publicado: (2006)

Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
por: Moore, John P
Publicado: (2006)

The frequencies of naturally occurring protease inhibitor resistance mutations in HIV proviral sequences of drug naïve sex workers in Nairobi, Kenya and their correlation with host immune response driven positively selected mutations in HIV-1
por: Sampathkumar, Raghavan, et al.
Publicado: (2014)

Peptide therapy in sepsis and inflammation: a novel strategy to suppress inflammation
por: Okada, Hidechika, et al.
Publicado: (2012)

International perspectives on adherence and resistance to HIV antiretroviral therapy
por: Bangsberg, D
Publicado: (2010)

Development of a CCR5-tropic HIV-1 fusion inhibition assay amenable to high-throughput screening for topical microbicides
por: Beer, B, et al.
Publicado: (2006)

New transcription regulatory mechanisms of latent HIV LTR
por: Rafati, Haleh, et al.
Publicado: (2012)

Novel insights into innate sensing of HIV-infected cells
por: Schwartz, Olivier
Publicado: (2011)

MRS2179: a novel inhibitor of platelet function
por: Dunne, H, et al.
Publicado: (2015)

Interactions of different drug resistance mutations in HIV Reverse Transcriptase in defining patterns of drug resistance
por: Wainberg, Mark A
Publicado: (2011)

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA
por: Booth, Clare L, et al.
Publicado: (2014)

P400 A study of the ecology, evolution and resistance mechanism of Candida auris at a tertiary care center in North India
por: Gupta, Sonakshi, et al.
Publicado: (2022)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Fusion of mental health and incapacity legislation
por: Szmukler, George, et al.
Publicado: (2007)

P291 Aspergillosis: another force to reckon with during COVID-19 times
por: Singla, Nidhi, et al.
Publicado: (2022)

Regional coronary endothelial dysfunction is related to local epicardial fat in HIV+ patients
por: Hays, Allison, et al.
Publicado: (2016)

SO4-05 OA. The intracellular production of HIV antigenic peptides is guided by predictable motifs and can be altered: implications for immunogen design
por: Lazaro, E, et al.
Publicado: (2009)

Analysis of the HIV resistance related HLA dRB1 restricted CD4+ T cell epitopes among Indian HIV patients
por: Christy, H Jemmy, et al.
Publicado: (2014)

Molecular mechanisms of resistance to HER2-targeted therapy
por: Esteva, FJ
Publicado: (2009)

Coronary artery distensibility is impaired in HIV patients without significant coronary atherosclerosis
por: Petrose, Lia, et al.
Publicado: (2016)

A laser device for fusion of nasal mucosa
por: Larson, Michael, et al.
Publicado: (2010)

Analysis of drug resistance to HIV-1 protease using fitness function in genetic algorithm
por: Harishchander, A, et al.
Publicado: (2012)

HIV-1 pathogenesis: IFN-alpha-dependent and -independent mechanisms of T cell death and unresponsiveness
por: Herbeuval, Jean-Philippe, et al.
Publicado: (2006)

OA011-02. Defining the mechanisms of HIV entry and interactions with the female genital tract
por: Carias, AM, et al.
Publicado: (2009)

Toll like Receptors (TLRs) expression in HIV children
por: Madeshwaran, M, et al.
Publicado: (2014)

A novel mechanism underlying pathogenesis of Down syndrome
por: Wang, Xin, et al.
Publicado: (2013)

Use of MRI fusion second-look ultrasound in breast cancer: can MRI US fusion reduce the need for MRI-guided biopsy?
por: McWilliams, SE
Publicado: (2012)

Novel pathways of transcriptional and post-transcriptional regulation of post-integrative HIV-1 latency
por: Marcello, A, et al.
Publicado: (2010)

LEDGINs, a novel class of antivirals targeting HIV integrase during integration and assembly
por: Debyser, Zeger
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fvk4rorufb9g93iah43hg7ek2f